Faraha Ahmed, Mohammad Ahmed Khan*, Nafis Haider, Mohammad Zaki Ahmad and Javed Ahmad*
Early detection and accurate monitoring are two critical factors affecting the outcome of anticancer therapy. However, both these factors are affected by the limitations of conventional approaches of diagnosis and treatment. Nanomedicine has progressively offered a scientific solution in improved delivery and better diagnosis of various cancers, thus providing a targeted treatment approach. With the advances in the field, simultaneous delivery and diagnosis are becoming a reality. The present manuscript discusses various drug delivery challenges, provides the scope for theranostic nanomaterials in the diagnosis and treatment of cancer. The clinical and translational potential of theranostic nanomedicine and the future directions for further research are also presented in the manuscript.
Nanomedicine; Theranostics; Cancer; Chemotherapy; Drug Delivery, Nanomaterials in Cancer
Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi -110062, Prince Sultan Military College of Health Sciences, Dhahran 34313, Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Department of Pharmaceutics, College of Pharmacy, Najran University, Najran